Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Price

Showing results (71-80 of 153) with videos related to

Pageof 16
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 13, 2013
The cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: results from the Australasian phase III MAX studyHannah E Carter, Diana Zannino, R John Simes, et al.
Acta Oncologica (Stockholm, Sweden)|February 16, 2016
Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registryYoko Tomita, Christos S Karapetis, Shahid Ullah, et al.
Molecular Diagnosis & Therapy|December 31, 2015
BRAF Mutation Testing and Metastatic Colorectal Cancer in the Community Setting: Is There an Urgent Need for More Education?Timothy J Price, Carol Beeke, Amanda Rose Townsend, et al.
ACS Applied Materials & Interfaces|November 5, 2014
Nanostructured polystyrene well plates allow unbiased high-throughput characterization of circulating tumor cellsYuan Wan, Marnie Winter, Bahman Delalat, et al.
Critical Reviews in Clinical Laboratory Sciences|February 11, 2021
Immunohistochemistry features and molecular pathology of appendiceal neoplasmsReger R Mikaeel, Joanne P Young, Gonzalo Tapia Rico, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2011
Impact of age on choice of chemotherapy and outcome in advanced colorectal cancerMuhammad A Khattak, Amanda R Townsend, Carol Beeke, et al.
Epigenetics|February 12, 2019
Reduced aquaporin-1 transcript expression in colorectal carcinoma is associated with promoter hypermethylationEric Smith, Yoko Tomita, Helen M Palethorpe, et al.
BMC Cancer|February 26, 2014
Can we accurately report PTEN status in advanced colorectal cancer?Christopher Hocking, Jennifer E Hardingham, Vy Broadbridge, et al.
Clinical Colorectal Cancer|January 27, 2010
Current Opinion on Optimal Treatment Choices in First-line Therapy for Advanced or Metastatic Colorectal Cancer: Report From the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September 2008Timothy J Price, Niall C Tebbutt, Christos S Karapetis, et al.
Cancer|September 20, 2012
A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal CancerRajiv Kumar, Kunal Jain, Carol Beeke, et al.
Pageof 16

Showing results (71-80 of 153) with videos related to

Sort By:
Pageof 16
European Journal of Cancer (Oxford, England : 1990)|November 13, 2013
The cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: results from the Australasian phase III MAX studyHannah E Carter, Diana Zannino, R John Simes, et al.
Acta Oncologica (Stockholm, Sweden)|February 16, 2016
Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registryYoko Tomita, Christos S Karapetis, Shahid Ullah, et al.
Molecular Diagnosis & Therapy|December 31, 2015
BRAF Mutation Testing and Metastatic Colorectal Cancer in the Community Setting: Is There an Urgent Need for More Education?Timothy J Price, Carol Beeke, Amanda Rose Townsend, et al.
ACS Applied Materials & Interfaces|November 5, 2014
Nanostructured polystyrene well plates allow unbiased high-throughput characterization of circulating tumor cellsYuan Wan, Marnie Winter, Bahman Delalat, et al.
Critical Reviews in Clinical Laboratory Sciences|February 11, 2021
Immunohistochemistry features and molecular pathology of appendiceal neoplasmsReger R Mikaeel, Joanne P Young, Gonzalo Tapia Rico, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2011
Impact of age on choice of chemotherapy and outcome in advanced colorectal cancerMuhammad A Khattak, Amanda R Townsend, Carol Beeke, et al.
Epigenetics|February 12, 2019
Reduced aquaporin-1 transcript expression in colorectal carcinoma is associated with promoter hypermethylationEric Smith, Yoko Tomita, Helen M Palethorpe, et al.
BMC Cancer|February 26, 2014
Can we accurately report PTEN status in advanced colorectal cancer?Christopher Hocking, Jennifer E Hardingham, Vy Broadbridge, et al.
Clinical Colorectal Cancer|January 27, 2010
Current Opinion on Optimal Treatment Choices in First-line Therapy for Advanced or Metastatic Colorectal Cancer: Report From the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September 2008Timothy J Price, Niall C Tebbutt, Christos S Karapetis, et al.
Cancer|September 20, 2012
A population-based study of metastatic colorectal cancer in individuals aged ≥ 80 years: findings from the South Australian Clinical Registry for Metastatic Colorectal CancerRajiv Kumar, Kunal Jain, Carol Beeke, et al.
Pageof 16